Senior Director External Innovation

Eli Lilly

Fellow of Royal Society of Chemistry (FRSC). A highly motivated and experienced drug hunter with a strong track record of leadership, delivery and scientific innovation. Proven ability to add significant portfolio value via internal and externalized drug discovery models.

Solve complex problems and consistently achieve top tier results across global boundaries in large and small pharma environments. Have co-created a successful spin out biotech which was acquired. Responsible for design and delivery of multiple diverse candidate drugs into clinical development. Inventor/author on more than 60 patent applications and publications. Able to build collaborative productive relationships and execute complex deals.

Specialties: drug discovery, technical evaluation, external innovation, emerging technology, medicinal chemistry, director, spin out biotech founder, project leader, risk assessment of strategy, competitive intelligence, predictive science, externalization, performance management.